Patents by Inventor Maria del Roser CALVO VERGES

Maria del Roser CALVO VERGES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190240242
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof in combination with Azacitidine or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Type: Application
    Filed: April 16, 2019
    Publication date: August 8, 2019
    Inventors: Dorothea RUDOLPH, Maria del Roser CALVO VERGES, Tillmann TAUBE
  • Publication number: 20170157158
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof in combination with Azacitidine or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Type: Application
    Filed: February 24, 2017
    Publication date: June 8, 2017
    Inventors: Dorothea RUDOLPH, Maria del Roser CALVO VERGES, Tillmann TAUBE
  • Publication number: 20150031643
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof in combination with Azacitidine or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Type: Application
    Filed: July 24, 2014
    Publication date: January 29, 2015
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Dorothea RUDOLPH, Maria del Roser CALVO VERGES, Tillmann TAUBE